Fetal biometry following in-utero exposure to dolutegravir-based or efavirenz-based antiretroviral therapy

被引：2
|
作者：
Banda, Francis M. [1 ]
Powis, Kathleen M. [2 ,3 ,4 ,5 ]
Sun, Shan [6 ]
Makhema, Joseph [2 ]
Masasa, Gosego [2 ]
Yee, Lynn M. [7 ]
Jao, Jennifer [2 ,8 ,9 ]
机构：
[1] Univ Botswana, Dept Paediat & Adolescent Hlth, Fac Med, P Bag 00713, Gaborone, Botswana
[2] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana
[3] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA
[6] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA
[7] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA
[8] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
[9] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
AIDS | 2020年 / 34卷 / 15期
关键词：
D O I：
10.1097/QAD.0000000000002674
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2336 / 2337
页数：2
相关论文
共 50 条
  • [41] Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV
    Banda, Clifford G.
    Nkosi, Dumisile
    Allen, Elizabeth
    Workman, Lesley
    Madanitsa, Mwayiwawo
    Chirwa, Marumbo
    Kapulula, Mayamiko
    Muyaya, Sharon
    Munharo, Steven
    Tarning, Joel
    Phiri, Kamija S.
    Mwapasa, Victor
    ter Kuile, Feiko O.
    Maartens, Gary
    Barnes, Karen I.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
  • [42] Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa
    Asare, Kwabena
    Lewis, Lara
    van der Molen, Johan
    Sookrajh, Yukteshwar
    Khubone, Thokozani
    Moodley, Pravikrishnen
    Lessells, Richard J.
    Naidoo, Kogieleum
    Sosibo, Phelelani
    Garrett, Nigel
    Dorward, Jienchi
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (12):
  • [43] Immunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus Infection
    Chan, Phillip
    Yoon, Bohyung
    Colby, Donn
    Kroon, Eugene
    Sacdalan, Carlo
    Sriplienchan, Somchai
    Pinyakorn, Suteeraporn
    Ananworanich, Jintanat
    Valcour, Victor
    Vasan, Sandhya
    Hsu, Denise
    Phanuphak, Nittaya
    Paul, Robert
    Spudich, Serena
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E718 - E726
  • [44] Treatment Outcomes of Dolutegravir- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Treatment-Naive People Living With HIV
    Mahale, Prarthana R.
    Patel, Brijalkumar S.
    Kasmani, Navsin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [45] Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho
    Brown, Jennifer A.
    Nsakala, Bienvenu L.
    Mokhele, Kuena
    Rakuoane, Itumeleng
    Muhairwe, Josephine
    Glass, Tracy R.
    Amstutz, Alain
    Tschumi, Nadine
    Belus, Jennifer M.
    Klimkait, Thomas
    Labhardt, Niklaus D.
    HIV MEDICINE, 2023, 24 (02) : 153 - 162
  • [46] Viral load non-suppression status among women exposed to Dolutegravir-based versus Efavirenz-based regimens in Ethiopia: A before-and-after study
    Facha, Wolde
    Tadesse, Takele
    Wolka, Eskinder
    Astatkie, Ayalew
    PLOS ONE, 2024, 19 (06):
  • [47] Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy
    Bourgi, Kassem
    Rebeiro, Peter
    Turner, Megan
    Castilho, Jessica L.
    Hulgan, Todd
    Raffanti, Stephen P.
    Koethe, John R.
    Sterling, Timothy R.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1267 - 1274
  • [48] Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women
    Hughes, Emma
    Mwebaza, Norah
    Huang, Liusheng
    Kajubi, Richard
    Nguyen, Vy
    Nyunt, Myaing M.
    Orukan, Francis
    Mwima, Moses W.
    Parikh, Sunil
    Aweeka, Francesca
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 83 (02) : 140 - 147
  • [49] OxytocinSlow fetal heart rate following in-utero exposure: case report
    Reactions Weekly, 2024, 2031 (1) : 322 - 322
  • [50] Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART; a comparative cross-sectional study
    Jemal, Mohammed
    Molla, Tewodros Shibabaw
    G. Medhin, Markeshaw Tiruneh
    Abebe, Endeshaw Chekol
    Dejenie, Tadesse Asmamaw
    ANNALS OF MEDICINE, 2023, 55 (02)
12345